fda compounding glp-1 enforcement news today says that the shortage is over FDA steps up crackdown on

Weight Management as a Central Therapeutic Pillar The 2026 standards further integrate obesity care into diabetes management

And we believe there is a place for mandatory serious adverse events reporting related to these substances. What could the future look like

Additional published context on Bioma's synbiotic formulation approach is available through a 2025 prebiotic, probiotic, and postbiotic synergy overview and an earlier consumer informational piece on probiotic supplement category developments

And trust meI know cold

They differ in formulation and are prescribed only pursuant to an individualized medical determination by a licensed healthcare provider